Cite

    Wang, X. et al. (2022). T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma. Journal for immunotherapy of cancer. 10 (6), p. . [Online].